|
|
Baxter Ventures was created in 2011 by Baxter International which has an 90-year legacy of healthcare innovation and saving and sustaining lives worldwide. With up $200 million in capital, Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. The firm's focus includes therapeutic areas complementary to those of Baxter's Medical Products and BioScience businesses. Areas of interest include: Acute and Intensive Care Pharmaceuticals, Anesthesia, BioSurgery, Clinical Nutrition, Critical Care, Fluid Management Systems, Hematologic Malignancies, Hematology/Hemophilia, Home Care Therapies, Immunology/ Inflammation, Infusion Systems/IV Tubing, Oncology, Pharmaceuticals/ Solutions/ Drug Delivery, Pulmonology, Rare/Orphan Diseases, Regenerative Medicine, Renal/ Dialysis Drugs and Devices, and Vaccines.
|
